Apr 5 |
What Makes Aptose Biosciences (APTO) a New Buy Stock
|
Mar 27 |
Aptose Biosciences Inc. (NASDAQ:APTO) Q4 2023 Earnings Call Transcript
|
Mar 27 |
Aptose Biosciences Inc. (APTO) Q4 2023 Earnings Call Transcript
|
Mar 26 |
Aptose Biosciences GAAP EPS of -$7.58 beats by $0.40
|
Mar 26 |
Aptose Reports Results for the Fourth Quarter and Full Year 2023
|
Mar 25 |
Aptose Biosciences Q4 2023 Earnings Preview
|
Mar 18 |
Aptose to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update on Tuesday, March 26, 2024
|
Feb 5 |
Assertio (ASRT) Stock Plunges 65% in 3 Months: Here's Why
|
Jan 31 |
Aptose Announces Closing of $9.7 Million Public Offering and Concurrent $4 Million Private Placement with Hanmi Pharmaceutical, Including Full Exercise of Over-Allotment Option
|
Jan 29 |
This Aptose Biosciences Insider Increased Their Holding In The Last Year
|